Plasma fractionation is a process employed to purify andseparate plasma into individual protein components. These fractionates are thenpurified, which can further be used as therapeutic medicines, known asplasma-derived therapies or plasma-derived medicinal products. This involves asequence of processes, including precipitation / chromatography, purification,and virus-inactivation. Plasma fractionation is a highly developed bioprocessthat can be carried out from small scale to commercial scale production. It isworth highlighting that more than 30 unique therapeutic plasma proteins havealready been developed through plasma fractionation which helps to treatvarious indications.

The global plasma fractionation market size is $ 5.3billion in 2025, is projected to reach $ 5.8 billion in 2026 and $ 12.7 billionby 2035, representing a higher CAGR of 9.1% during the forecast period 2026 to2035.

https://www.rootsanalysis.com/reports/plasma-fractionation-market.html